Nicole Habel, MD
Cardiovascular Disease · Middlebury, VTNPI 1881081370
Payments from drug & device makers
What this record shows
This record is dominated by grants: $84,000 of the $129,533 with a category attached, or 64.8%. Medtronic accounts for 79.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $52,934 and has fallen 50.6% since, to $26,128 in 2025. Among cardiovascular disease clinicians in VT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $918.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$103K
- Medical Device Business Services, Inc.$17K
- Abbott$8K
- Biosense Webster, Inc.$1K
- Boston Scientific$320
Across 5 payments — averaging $8092.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$40K
What the payments were for
- Consulting fees$15,07512%
- Speaking & faculty fees$18,37514%
- Grants$84,00065%
- Travel & lodging$6,6575%
- Food & beverage$4,6884%
- Education$7381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 111 | $103,499 |
| Medical Device Business Services, Inc. | 17 | $16,772 |
| Abbott | 4 | $7,715 |
| Biosense Webster, Inc. | 6 | $1,228 |
| Boston Scientific | 3 | $320 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$17,634
- SelectSecure$1,817
- RHYTHMIA$190
- Ensite Cardiac Mapping System$150
- Micra$114
- Amplia MRI$113
- Arctic Front$100
How this compares
$129,533 in reported general payments places this provider in the 90th percentile of 27 cardiovascular disease providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $31,927 |
| Dofetilide | 11 | $1,640 |
| Amlodipine Besylate | 19 | $139 |
| Carvedilol | 13 | $123 |
| Metoprolol Succinate | 11 | $114 |
| Atorvastatin Calcium | 17 | $75 |
| Pantoprazole Sodium | 13 | $71 |
| Hydrochlorothiazide | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Middlebury
- Tyler WarkMiddlebury$393
- Harold DauermanBurlington$248K
- Daniel LustgartenBurlington$171K
- Shubash AdhikariBurlington$59K
- Adipong BrickshawanaBurlington$37K
- Thomas GillilandBurlington$35K
- Martin LewinterSouth Burlington$15K
- Benjamin IrvineBurlington$11K
- David SchneiderBurlington$7K
- Peter VanburenSouth Burlington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.